Watch Tuesday: MFN, tariffs and a DTC push — Inside Trump’s drug-pricing reset

Dr. Oz to Newsmax: TrumpRx to Deliver Drug Price Parity

Dr. Mehmet Oz, the Centers for Medicare and Medicaid Services administrator, told Newsmax on Saturday that President Donald Trump’s new TrumpRx program will ensure Americans pay no more for prescription drugs than other developed nations, calling it a “Most Favored Nation” pricing revolution.Oz, a cardiothoracic surgeon, appeared Saturday on “America Right Now” to explain how President Donald Trump’s new TrumpRx initiative will deliver lower, fa…

Watch Tuesday: MFN, tariffs and a DTC push — Inside Trump’s drug-pricing reset

Part three of our three-part webinar series airs Nov. 4 at 7 p.m. ET, unpacking how most favored nation pricing, import tariffs and direct-to-consumer channels could ripple through payer contracts, 340B and practice economics.

Trump’s Pharma Agreements Signal A Shift Toward Direct-To-Consumer Pricing – RamaOnHealthcare

President Trump’s recent agreements with Pfizer and AstraZeneca have drawn attention for lowering drug costs and incentivizing domestic manufacturing. Equally important, they make direct-to-consumer purchasing a national priority, an evolution that could reset industry incentives.Direct-to-consumer pricing isn’t new, but its integration into federal policy is. If implemented thoughtfully, it could lower costs by advancing transparency, [...]